About Ra Chem Pharma
Ra Chem Pharma is a company based in Hyderabad (India) founded in 1996 by Ravi K Yerra and J Rajender Rao was acquired by Advent International in July 2020.. Ra Chem Pharma has raised $3.78 million across 4 funding rounds from investors including Joflo Industries, Ontario and Orchem International Trading. The company has 1,138 employees as of April 05, 2024. Ra Chem Pharma operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Hyderabad, India
- Employees 1138 as on 05 Apr, 2024
- Founders Ravi K Yerra, J Rajender Rao
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ra Chem Pharma Limited
- Date of Incorporation 08 Jan, 1996
- Jurisdiction Hyderabad, Andhra Pradesh, India
-
Annual Revenue
$44.18 M (USD)16.47as on Mar 31, 2016
-
Net Profit
$3.4 M (USD)57.72as on Mar 31, 2016
-
EBITDA
$7.96 M (USD)36.71as on Mar 31, 2016
-
Total Equity Funding
$3.78 M (USD)
in 4 rounds
-
Latest Funding Round
$339.58 K (USD), Unspecified
Jun 20, 2013
-
Investors
Joflo Industries
& 5 more
-
Employee Count
1138
as on Apr 05, 2024
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ra Chem Pharma
Ra Chem Pharma has successfully raised a total of $3.78M across 4 strategic funding rounds. The most recent funding activity was a Unspecified round of $339.58 thousand completed in June 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Unspecified — $339,584
-
First Round
First Round
(25 Aug 2006)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2013 | Amount | Unspecified - Ra Chem Pharma | Valuation | Ontario , Orchem International Trading |
|
| Oct, 2011 | Amount | Unspecified - Ra Chem Pharma | Valuation | Ontario , Orchem International Trading |
|
| Sep, 2008 | Amount | Unspecified - Ra Chem Pharma | Valuation | Ontario , Orchem International Trading |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ra Chem Pharma
Ra Chem Pharma has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Joflo Industries, Ontario and Orchem International Trading. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Pharmaceutical products, medical instruments, and orthopaedic articles are wholesaled internationally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ra Chem Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ra Chem Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ra Chem Pharma Comparisons
Competitors of Ra Chem Pharma
Ra Chem Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| domain | founded_year | HQ Location |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| domain | founded_year | HQ Location |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| domain | founded_year | HQ Location |
APIs and finished products are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| domain | founded_year | HQ Location |
APIs and peptides are developed and manufactured by Asymchem.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ra Chem Pharma
Frequently Asked Questions about Ra Chem Pharma
When was Ra Chem Pharma founded?
Ra Chem Pharma was founded in 1996 and raised its 1st funding round 10 years after it was founded.
Where is Ra Chem Pharma located?
Ra Chem Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Is Ra Chem Pharma a funded company?
Ra Chem Pharma is a funded company, having raised a total of $3.78M across 4 funding rounds to date. The company's 1st funding round was a Unspecified of $1.71M, raised on Aug 25, 2006.
How many employees does Ra Chem Pharma have?
As of Apr 05, 2024, the latest employee count at Ra Chem Pharma is 1,138.
What is the annual revenue of Ra Chem Pharma?
Annual revenue of Ra Chem Pharma is $44.18M as on Mar 31, 2016.
What does Ra Chem Pharma do?
RA Chem Pharma is a contract developer manufacturer of API formulations. They provide bioanalytical services such as HPLC GC, synthesize impurities working standards. Their API products are duloxetine, venlafaxine, orlistat, itraconazole, etc. The company is specialized in formulations development of oral control release site-specific release deliveries for anti-spasmodic, non-steroidal anti-inflammatory, anti-anxieties alpha1 receptor blockers. The company also claims to have completed more than three hundred BABE studies for various regulatory agencies.
Who are the top competitors of Ra Chem Pharma?
Ra Chem Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Who are Ra Chem Pharma's investors?
Ra Chem Pharma has 6 investors. Key investors include Joflo Industries, Ontario, Orchem International Trading, Laxmi RA, and Advent International.
What is Ra Chem Pharma's valuation?
The valuation of Ra Chem Pharma is $17.09M as of Jun 2013.